Yield10 Bioscience - YTEN Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $10.50
  • Forecasted Upside: 167.18%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$3.93
▲ +0.09 (2.34%)

This chart shows the closing price for YTEN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Yield10 Bioscience Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for YTEN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for YTEN

Analyst Price Target is $10.50
▲ +167.18% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Yield10 Bioscience in the last 3 months. The average price target is $10.50, with a high forecast of $12.00 and a low forecast of $9.00. The average price target represents a 167.18% upside from the last price of $3.93.

This chart shows the closing price for YTEN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 contributing investment analysts is to buy stock in Yield10 Bioscience.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/15/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/13/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/11/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/12/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/10/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/8/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/7/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/6/2023

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/3/2022Univest SecInitiated CoverageBuyMedium
4/21/2022Lake Street CapitalInitiated CoverageBuy$12.00High
3/10/2022Maxim GroupLower TargetBuy$18.00 ➝ $9.00High
2/9/2021Maxim GroupBoost TargetBuy$12.00 ➝ $24.00Low
9/10/2020HC WainwrightInitiated CoverageBuy$25.00High
8/27/2020National SecuritiesUpgradeNeutral ➝ Buy$15.00High
8/13/2020Maxim GroupReiterated RatingBuy$12.00Low
5/15/2020Maxim GroupReiterated RatingBuy$12.00High
5/15/2020National SecuritiesReiterated RatingHold$10.00High
3/20/2020National SecuritiesReiterated RatingHoldHigh
12/11/2019LADENBURG THALM/SH SHLower Target$280.00 ➝ $40.00Low
11/18/2019National SecuritiesDowngradeBuy ➝ NeutralHigh
11/15/2019Maxim GroupReiterated RatingBuy$20.00High
8/20/2019National SecuritiesReiterated RatingBuy ➝ Buy$200.00Low
8/13/2019AegisReiterated RatingBuy$80.00High
8/13/2019National SecuritiesReiterated RatingBuy ➝ Buy$200.00 ➝ $200.00High
7/22/2019AegisInitiated CoverageBuyHigh
5/31/2019Maxim GroupReiterated RatingBuy ➝ Buy$120.00High
5/10/2019National SecuritiesReiterated RatingBuy ➝ Buy$200.00Low
5/10/2019Maxim GroupReiterated RatingBuy$180.00Low
3/26/2019National SecuritiesReiterated RatingBuy ➝ Buy$200.00 ➝ $200.00Low
3/26/2019Maxim GroupSet TargetBuy$200.00Low
1/23/2019National SecuritiesInitiated CoverageBuy$200.00Medium
9/21/2018Maxim GroupReiterated RatingBuy$280.00High
7/12/2018Maxim GroupInitiated CoverageBuy$280.00High
(Data available from 2/7/2018 forward)

News Sentiment Rating

0.34 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/11/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/10/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/9/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/9/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/8/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
12/8/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/7/2023
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/6/2023

Current Sentiment

  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Yield10 Bioscience logo
Yield10 Bioscience, Inc. operates as an agricultural bioscience company. It focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.
Read More

Today's Range

Now: $3.93
Low: $3.73
High: $3.96

50 Day Range

MA: $2.45
Low: $1.66
High: $4.10

52 Week Range

Now: $3.93
Low: $1.63
High: $7.21

Volume

18,262 shs

Average Volume

741,937 shs

Market Capitalization

$19.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.73

Frequently Asked Questions

What sell-side analysts currently cover shares of Yield10 Bioscience?

The following sell-side analysts have issued reports on Yield10 Bioscience in the last year: Lake Street Capital, Maxim Group, and Univest Sec Llc.
View the latest analyst ratings for YTEN.

What is the current price target for Yield10 Bioscience?

2 Wall Street analysts have set twelve-month price targets for Yield10 Bioscience in the last year. Their average twelve-month price target is $10.50, suggesting a possible upside of 167.2%. Lake Street Capital has the highest price target set, predicting YTEN will reach $12.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $9.00 for Yield10 Bioscience in the next year.
View the latest price targets for YTEN.

What is the current consensus analyst rating for Yield10 Bioscience?

Yield10 Bioscience currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe YTEN will outperform the market and that investors should add to their positions of Yield10 Bioscience.
View the latest ratings for YTEN.

What other companies compete with Yield10 Bioscience?

How do I contact Yield10 Bioscience's investor relations team?

Yield10 Bioscience's physical mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The specialty chemicals company's listed phone number is (617) 583-1700 and its investor relations email address is [email protected] The official website for Yield10 Bioscience is www.yield10bio.com. Learn More about contacing Yield10 Bioscience investor relations.